CAMP

Conviction 45HealthcareScan · Mon, Aug 10, 2026

CAMP$4.24+0.00%

ResistanceSupportVol 14Insider buy

Vol MA14 249.4K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Camp4 Therapeutics CorpPHARMACEUTICAL PREPARATIONSwww.camp4tx.com ↗

Price4.24

Change+0.00%

Gap-2.36%

Rel volume5.24×

Avg volume240.19K

Avg $ vol935.71K

SMA 203.72

SMA 504.02

SMA 2004.44

Price vs 50+5.48%

Price vs 200-4.56%

MA stackmixed

50/200 cross—

Supertrendup · 3.16

RSI (14)57

MACD hist0.12

MACD crossbull · 5d

Stoch %K / %D79 / 84

ADX (14)24

+DI / −DI24 / 14

RSI divergence—

MACD divergence—

ATR %+9.17%

ADR %10.38%

52w high7.13

52w low1.36

From 52w high-40.53%

Above 52w low+211.76%

New 52w highNo

SqueezeOff

Bollinger width51.65%

%B0.77

Donchian pos74.03%

Donchian high4.71

Donchian low2.90

AVWAP (52w high)4.75

vs AVWAP high-10.77%

AVWAP (52w low)3.77

vs AVWAP low+12.34%

OBV trendFlat

Chaikin MF (20)0.06

Today vs 20d5.24×

Avg vol (14d)249.4K

Avg vol (20d)240.19K

Avg $ vol (20d)935.71K

Market cap220.17M

RS 3m (vs SPY)-8.00%

RS 6m (vs SPY)+3.99%

RS line new highNo

Trend template3/8

Technical rank39.8

1 week+0.71%

1 month-2.08%

3 months-4.93%

6 months+10.42%

1 year+196.50%

YTD-29.33%

P/E-2.74

P/B7.12

P/S—

P/FCF-7.38

EPS-2.65

Div yield—

ROE-260.19%

ROA-76.24%

Debt/Eq—

Current6.15

EV/EBITDA-2.38

Gross margin—

Net margin—

Rev growth—

EPS growth-55.25%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value120.96M

Revenue795K

Net income-18.33M

Gross profit—

Free cash flow-29.83M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out51.93M

Employees48

ListedFri, Oct 11, 2024

Free float28.84M

Float %55.5%

Short interest1.44M

Days to cover9.1d

Short volume56.6%

Squeeze score61 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction45 / 100

Pattern quality—

Tech rank39.8 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.98

Support2.95

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CAMP

All disclosures →

No recent disclosed trades by Congress in CAMP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CAMP · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Young Richard A Director · Common Stock · 2026-08-03	Buy	16.38K	$27K	2026-08-03	2026-08-05
5AM Partners VI, LLC 10% owner · Pre-Funded Warrant (Right to Buy) · 2026-08-03	Buy	3.18M	$4.9M	2026-08-03	2026-08-05
Schwab Andrew J. Director · Pre-Funded Warrant (Right to Buy) · 2026-08-03	Grant	3.18M	$4.9M	2026-08-03	2026-08-05
Mandel-Brehm Josh Chief Executive Officer · Common Stock · 2026-08-03	Buy	6.55K	$11K	2026-08-03	2026-08-05
Gold Kelly Chief Financial Officer · Common Stock · 2026-08-03	Buy	6.55K	$11K	2026-08-03	2026-08-05
Maricich Yuri Chief Medical Officer · Common Stock · 2026-08-03	Buy	6.55K	$11K	2026-08-03	2026-08-05

SEC filings

EDGAR filings in CAMP · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.